Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
C2M Group appears to be an active medical technology product-development and consulting company focused on helping innovators bring medical device products and platforms to market. Publicly available descriptions emphasize medtech expertise spanning product design, engineering, and marketing, with a collaborative development approach and use of a V-model product-development process. The company does not appear to be a drug-discovery biotech or therapeutics developer; instead, it is best characterized as a medtech-focused service and development organization. Based on the available evidence, C2M Group is healthcare-related through its medical device focus, but there is insufficient public information to identify a therapeutic pipeline, molecular targets, or drug modalities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on C2M Group.